Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II—results

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

A. Laupacis, David Feeny, Allan S. Detsky et al. · PubMed · 1992 · 1.6K citations

Pharmacy, Pharmacoeconomics, Health Economics +16

The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia

Herbert Lepor, William O. Williford, Michael J. Barry et al. · New England Journal of Medicine · 1996 · 799 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +15

A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia

John H. Wasson, Domenic J. Reda, Reginald C. Bruskewitz et al. · New England Journal of Medicine · 1995 · 611 citations

Medicine, Surgery, Urology +8

Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies

Alan L. Hillman, John M. Eisenberg, Mark V. Pauly et al. · New England Journal of Medicine · 1991 · 238 citations

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +14

The hytrin community assessment trial study: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia

Claus G. Roehrborn, Joseph E. Oesterling, Stephen M. Auerbach et al. · Urology · 1996 · 210 citations

Medicine, Pharmacology, Pharmacotherapy +5